RGEN Q3 2019 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

Q3 2019 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$69M+40.2% YoY

Gross Profit

$38M54.7% margin

Operating Income

$8M11.5% margin

Net Income

$2M2.4% margin

EPS (Diluted)

$0.03

QoQ Revenue Growth

-1.8%

Cash Flow

Operating Cash Flow

$22M

Free Cash Flow

$15M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$1.4B

Total Liabilities

$334M

Stockholders' Equity

$1.0B

Cash & Equivalents

$513M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$69M	$50M	+40.2%
Gross Profit	$38M	$27M	+39.0%
Operating Income	$8M	$8M	+1.0%
Net Income	$2M	$5M	-65.4%

Revenue Segments

Product

$69M100%

Royalty

$26,0000%